BioNano Genomics, Inc Contracts & Agreements
129 Contracts & Agreements
- Business Finance (68 contracts)
- Business Operations (5)
- Human Resources (18)
- Intellectual Property (10)
- Mergers & Acquisitions (3)
- Real Estate (10)
- Uncategorized (15)
- Form of Warrant (Filed With SEC on April 5, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on April 5, 2024)
- Form of Securities Purchase Agreement dated April 4, 2024 between Bionano Genomics, Inc. and the purchasers party thereto (Filed With SEC on April 5, 2024)
- Form of Common Stock Certificate (Filed With SEC on March 5, 2024)
- Description of the Companys Securities (Filed With SEC on March 5, 2024)
- Letter Agreement between the Company and the Purchaser, dated February 27, 2024 (Filed With SEC on February 28, 2024)
- Amendment to Initial Registered Note issued to the Purchaser, dated February 27, 2024 (Filed With SEC on February 28, 2024)
- Second Amendment to Agreement and Plan of Merger, dated July 15, 2023, by and among the Company, Starship Merger Sub I, Inc., Starship Merger Sub II, LLC, BioDiscovery, Inc. and... (Filed With SEC on November 8, 2023)
- Employment Agreement, effective as of September 11, 2023, by and between Glsen Kama and the Company (Filed With SEC on November 8, 2023)
- Transition, Separation and Consulting Agreement dated as of August 11, 2023, by and between Christopher Stewart and the Company (Filed With SEC on November 8, 2023)
- Form of Note, representing the Companys Senior Secured Convertible Notes due 2025 (Filed With SEC on October 11, 2023)
- Form of Warrant to Purchase Common Stock (Filed With SEC on October 11, 2023)
- Securities Purchase Agreement, dated October 11, 2023, by and among the Company and the Purchaser named therein (Filed With SEC on October 11, 2023)
- Amendment No. 1 to Sales Agreement, dated March 9, 2023, by and between the Company and Cowen and Company, LLC (Filed With SEC on May 9, 2023)
- Purchase Agreement, dated April 13, 2023, by and between Bionano Genomics, Inc. and David Barker (Filed With SEC on April 14, 2023)
- Description of the Companys Securities (Filed With SEC on March 9, 2023)
- Forms of grant notice, stock option agreement and notice of exercise under the 2018 Plan (Filed With SEC on March 9, 2023)
- Forms of director grant notice, stock option agreement and notice of exercise under the 2018 Plan (Filed With SEC on March 9, 2023)
- Forms of double-trigger grant notice, stock option agreement and notice of exercise under the 2018 Plan (Filed With SEC on March 9, 2023)
- Lease, dated August 22, 2016, by and between SFF BBC, LLC and Purigen Biosystems, Inc (Filed With SEC on March 9, 2023)
- First Amendment to the Lease by and between Purigen Biosystems Inc, and SFF BBC, LLC, dated August 22, 2016 (Filed With SEC on March 9, 2023)
- Amended and Restated Exclusive License Agreement with Equity, dated July 16, 2021, by and between The Board of Trustees of the Leland Stanford Junior University and Purigen... (Filed With SEC on March 9, 2023)
- Amendment No. 1 to the Amended and Restated Exclusive License Agreement Effective the 16th Day of July 2021 Between Stanford University and Purigen Biosystems, Inc., dated... (Filed With SEC on March 9, 2023)
- Bionano Genomics, Inc. Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 1, 2022)
- Standard Industrial/Commercial Single-Tenant Lease, made effective as of November 23, 2021, by and between the Company and 6777 Nancy Ridge LLC (Filed With SEC on March 1, 2022)
- Employment Agreement (Filed With SEC on March 1, 2022)
- Stock Restriction Agreement (Filed With SEC on March 1, 2022)
- Employment Agreement, dated June 14, 2021, by and between the Company and Richard Shippy (Filed With SEC on March 1, 2022)
- Commercial Single-Tenant Lease Net, dated February 28, 2016, by and between Tesa Beach LLC and BioDiscovery, Inc (Filed With SEC on March 1, 2022)
- Fifth Amendment to the Lease by and between the Registrant and The Irvine Company, LLC, dated January 12, 2022 (Filed With SEC on March 1, 2022)
- Non-Employee Director Compensation Policy, as Amended (Filed With SEC on November 4, 2021)
- Agreement and Plan of Merger, dated October 8, 2021, by and among the Company, Starship Merger Sub I, Inc., Starship Merger Sub II, LLC, BioDiscovery, Inc. and Soheil Shams (Filed With SEC on October 19, 2021)
- Bionano Genomics, Inc. 2020 Inducement Plan dated August 20, 2020, as amended (Filed With SEC on October 12, 2021)
- Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the Bionano Genomics, Inc. 2018 Equity Incentive Plan (Filed With SEC on August 4, 2021)
- Sales Agreement, dated March 23, 2021, by and between the Company and Cowen and Company, LLC (Filed With SEC on March 24, 2021)
- Description of the Companys Securities (Filed With SEC on March 23, 2021)
- Third Amendment to the Lease by and between the Registrant and The Irvine Company LLC, dated December 19, 2019 (Filed With SEC on March 23, 2021)
- Fourth Amendment to the Lease by and between the Registrant and The Irvine Company LLC, dated February 15, 2021 (Filed With SEC on March 23, 2021)
- Fourth Amendment to Loan and Security Agreement, dated December 30, 2020, by and among the Company, Lineagen, Inc., Innovatus Life Sciences Lending Fund I, LP and East West Bank (Filed With SEC on March 23, 2021)
- Underwriting Agreement, dated January 20, 2021, by and among Bionano Genomics, Inc. and Oppenheimer & Co. Inc., as representatives of the several underwriters named therein (Filed With SEC on January 21, 2021)
- Underwriting Agreement, dated January 8, 2021, by and among Bionano Genomics, Inc. and Oppenheimer & Co. Inc., as representatives of the several underwriters named therein (Filed With SEC on January 11, 2021)
- Consent and Third Amendment to Loan and Security Agreement, dated August 21, 2020, by and among the Company, Innovatus Life Sciences Lending Fund I, LP and East West Bank (Filed With SEC on November 13, 2020)
- Agreement and Plan of Merger, dated August 21, 2020, by and among the Company, Alta Merger Sub, Inc., Lineagen, Inc. and Michael S. Paul, Ph.D (Filed With SEC on November 13, 2020)
- Employment Agreement, effective as of September 1, 2020, by and between Christopher Stewart and the Company (Filed With SEC on November 13, 2020)
- Employment Agreement, effective as of August 31, 2020, by and between Alka Chaubey and the Company (Filed With SEC on November 13, 2020)
- Bionano Genomics, Inc. 2020 Inducement Plan (Filed With SEC on August 24, 2020)
- Form of Stock Option Grant Notice and Stock Option Agreement under the Bionano Genomics, Inc. 2020 Inducement Plan (Filed With SEC on August 24, 2020)
- Description of the Company's Securities (Filed With SEC on August 13, 2020)
- Form of Underwriting Agreement (Filed With SEC on March 24, 2020)
- Form of Warrant to Purchase Common Stock (Filed With SEC on March 24, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on March 24, 2020)
- Description of the Companys Securities (Filed With SEC on March 10, 2020)
- Second Amendment to Loan Agreement, dated March 6, 2020, by and among the Company, Innovatus Life Sciences Lending Fund I, LP and East West Bank (Filed With SEC on March 10, 2020)
- Form of Warrants Amendment and Agreement (Filed With SEC on March 2, 2020)
- Form of New Warrant (Filed With SEC on March 2, 2020)
- Form of Underwriting Agreement (Filed With SEC on October 17, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on October 17, 2019)
- Form of Underwriting Agreement (Filed With SEC on September 18, 2019)
- Form of Warrant to Purchase Common Stock (Filed With SEC on September 18, 2019)
- Waiver and First Amendment to Loan and Security Agreement, dated June 25, 2019, by and among the Company, Innovatus Life Sciences Lending Fund I, LP and East West Bank (Filed With SEC on August 8, 2019)
- Registration Rights Agreement, dated March 14, 2019, between the Company and Aspire Capital Fund, LLC (Filed With SEC on March 14, 2019)
- Form of Warrant to Purchase Common Stock for Innovatus (Filed With SEC on March 14, 2019)
- Registration Rights Agreement, dated March 14, 2019, by and among the Company and the Innovatus Investors (Filed With SEC on March 14, 2019)
- Common Stock Purchase Agreement, dated March 14, 2019, between the Company and Aspire Capital Fund, LLC (Filed With SEC on March 14, 2019)
- Common Stock Purchase Agreement, dated March 14, 2019, by and among the Company and the Innovatus Investors (Filed With SEC on March 14, 2019)
- Loan and Security Agreement, dated March 14, 2019, by and among the Company, Innovatus Life Sciences Lending Fund I, LP and the Lenders listed on Schedule 1.1 thereto (Filed With SEC on March 14, 2019)
- Form of Warrant to Purchase Common Stock for Service Providers (Filed With SEC on November 21, 2018)
- Amendment Agreement, dated November 19, 2018, by and between the Company and Western Alliance Bank, an Arizona corporation (Filed With SEC on November 21, 2018)
- Form of Underwriting Agreement (Filed With SEC on August 15, 2018)
- Form of Warrant Certificate (included in Exhibit 4.11) (Filed With SEC on August 15, 2018)
- Form of Unit Certificate (Filed With SEC on August 15, 2018)
- Fifth Amended and Restated Investors Rights Agreement, dated August 5, 2016 as amended (Filed With SEC on August 15, 2018)
- Bionano Genomics, Inc. 2018 Equity Incentive Plan (the 2018 Plan) (Filed With SEC on August 15, 2018)
- Bionano Genomics, Inc. 2018 Employee Stock Purchase Plan (Filed With SEC on August 15, 2018)
- Omnibus Amendment to Convertible Promissory Notes by and among the Registrant and the Holders identified in the signature pages thereto, dated August 14, 2018 (Filed With SEC on August 15, 2018)
- Omnibus Amendment to Warrants to Purchase Series B-1 Preferred Stock by and among the Registrant and the Holders identified in the signature pages thereto, dated August 14, 2018 (Filed With SEC on August 15, 2018)
- Omnibus Amendment to Warrants to Purchase Series D Preferred Stock by and among the Registrant and the Holders identified in the signature pages thereto, dated August 14, 2018 (Filed With SEC on August 15, 2018)
- Fifth Amended and Restated Investors Rights Agreement, dated August 5, 2016 as amended (Filed With SEC on July 31, 2018)
- Fifth Amended and Restated Investors Rights Agreement, dated August 5, 2016 as amended (Filed With SEC on July 19, 2018)
- Form of Underwriting Agreement (Filed With SEC on July 17, 2018)
- Form of Common Stock Certificate (Filed With SEC on July 17, 2018)
- Bionano Genomics, Inc. 2018 Equity Incentive Plan (the 2018 Plan) (Filed With SEC on July 17, 2018)
- Forms of grant notice, stock option agreement and notice of exercise under the 2018 Plan (Filed With SEC on July 17, 2018)
- Bionano Genomics, Inc. 2018 Employee Stock Purchase Plan (Filed With SEC on July 17, 2018)
- Form of Indemnification Agreement by and between the Registrant and each director and executive officer (Filed With SEC on July 17, 2018)
- Bionano Genomics, Inc. Non-Employee Director Compensation Policy (Filed With SEC on July 17, 2018)
- Form of Warrant to Purchase Series D-1 Preferred Stock issued to Midcap Financial Trust (Filed With SEC on July 13, 2018)
- Amendment to Patent Sublicense Agreement by and between the Registrant and Industry 3200, dated June 28, 2018 (Filed With SEC on July 13, 2018)
- Credit and Security Agreement by and between the Registrant, Midcap Financial Trust and the Lenders listed on the Schedule of Lenders attached thereto, dated June 29, 2018 (Filed With SEC on July 13, 2018)
- Second Amendment to Note Purchase Agreement by and between the Registrant and the Investors listed on the Schedule of Investors attached thereto, dated June 29, 2018 (Filed With SEC on July 13, 2018)
- Omnibus Amendment to Convertible Promissory Notes by and among the Registrant and the Holders identified in the signature pages thereto, dated June 29, 2018 (Filed With SEC on July 13, 2018)
- Form of Warrant to Purchase Series B Preferred Stock issued to Square 1 Bank (Filed With SEC on June 28, 2018)
- Form of Warrant to Purchase Series B-1 Preferred Stock issued to Square 1 Bank (Filed With SEC on June 28, 2018)
- Form of Warrant to Purchase Series B-1 Preferred Stock issued to investors (Filed With SEC on June 28, 2018)
- Form of Warrant to Purchase Series D Preferred Stock issued to Western Alliance Bank (Filed With SEC on June 28, 2018)
- Form of Warrant to Purchase Series D Preferred Stock issued to investors (Filed With SEC on June 28, 2018)
- Warrant to Purchase Series D-1 Preferred Stock issued to Western Alliance Bank (Filed With SEC on June 28, 2018)
- Fifth Amended and Restated Investors Rights Agreement, dated August 5, 2016 (Filed With SEC on June 28, 2018)
- Bionano Genomics, Inc. Amended and Restated 2006 Equity Compensation Plan (the 2006 Plan) (Filed With SEC on June 28, 2018)
- Forms of grant notice, stock option agreement and notice of exercise under the 2006 Plan (Filed With SEC on June 28, 2018)
- Employment Agreement by and between the Registrant and R. Erik Holmlin, Ph.D., dated November 7, 2017, as amended (Filed With SEC on June 28, 2018)
- Employment Agreement by and between the Registrant and Han Cao, Ph.D., dated November 7, 2017, as amended (Filed With SEC on June 28, 2018)
- Employment Agreement by and between the Registrant and Mike Ward, dated July 1, 2016 (Filed With SEC on June 28, 2018)
- Employment Agreement by and between the Registrant and Warren Robinson, dated November 7, 2017 (Filed With SEC on June 28, 2018)
- Employment Agreement by and between the Registrant and Mark Borodkin, dated November 7, 2017 (Filed With SEC on June 28, 2018)
- Loan and Security Agreement by and between the Registrant and Western Alliance Bank, dated March 8, 2016 (Filed With SEC on June 28, 2018)
- First Amendment to the Loan and Security Agreement by and between the Registrant and Western Alliance Bank, dated December 9, 2016 (Filed With SEC on June 28, 2018)
- Second Amendment to the Loan and Security Agreement by and between the Registrant and Western Alliance Bank, dated May 2, 2017 (Filed With SEC on June 28, 2018)
- Third Amendment to the Loan and Security Agreement by and between the Registrant and Western Alliance Bank, dated November 20, 2017 (Filed With SEC on June 28, 2018)
- Forbearance and Fourth Amendment to the Loan and Security Agreement by and between the Registrant and Western Alliance Bank, dated February 9, 2018 (Filed With SEC on June 28, 2018)
- Lease by and between the Registrant and The Irvine Company LLC, dated January 16, 2012 (Filed With SEC on June 28, 2018)
- First Amendment to the Lease by and between the Registrant and The Irvine Company LLC, dated September 10, 2013 (Filed With SEC on June 28, 2018)
- Second Amendment to the Lease by and between the Registrant and The Irvine Company LLC, dated July 1, 2015 (Filed With SEC on June 28, 2018)
- Master Services Agreement by and between the Registrant and Skorpios Technologies, Inc. (f/k/a Novati Technologies, Inc. and f/k/a SVTC Technologies, LLC), dated March 2, 2009, as... (Filed With SEC on June 28, 2018)
- Manufacturing Services Agreement by and between the Registrant and Paramit Corporation, dated February 18, 2015 (Filed With SEC on June 28, 2018)
- License Agreement by and between Princeton University and the Registrant, dated January 7, 2004 (Filed With SEC on June 28, 2018)
- First Amendment to the License Agreement by and between Princeton University and the Registrant, dated December 17, 2004 (Filed With SEC on June 28, 2018)
- Second Amendment to the License Agreement by and between Princeton University and the Registrant, dated February 25, 2010 (Filed With SEC on June 28, 2018)
- Third Amendment to the License Agreement by and between Princeton University and the Registrant, dated October 17, 2011 (Filed With SEC on June 28, 2018)
- Fourth Amendment License Agreement by and between Princeton University and the Registrant, dated February 9, 2012 (Filed With SEC on June 28, 2018)
- Agreement by and between the Registrant and Berry Genomics Co., Ltd. dated August 2, 2016 (Filed With SEC on June 28, 2018)
- Sublicense Agreement by and between the Registrant and Industry 3200 dated December 27, 2013 (Filed With SEC on June 28, 2018)
- License Agreement by and between the Registrant and Q Biotechnology CV dated May 1, 2014 (Filed With SEC on June 28, 2018)
- Amendment to Non-Exclusive Patent License Agreement by and between the Registrant and Q Biotechnology CV dated May 1, 2014 (Filed With SEC on June 28, 2018)
- License Agreement by and between the Registrant and New York University dated November 4, 2013 (Filed With SEC on June 28, 2018)
- Option and Sublicense Agreement by and between the Registrant and Pacific Biosciences of California, Inc. dated February 2, 2016 (Filed With SEC on June 28, 2018)
- Note Purchase Agreement by and among the Registrant and the Investors listed on Exhibit A thereto, dated February 9, 2018 (Filed With SEC on June 28, 2018)
- First Amendment to Note Purchase Agreement by and among the Registrant and the Investors listed on the Schedule of Investors attached thereto, dated April 2, 2018 (Filed With SEC on June 28, 2018)
- Fifth Amendment to Loan and Security Agreement by and between the Registrant and Western Alliance Bank, dated June 13, 2018 (Filed With SEC on June 28, 2018)